Webcast CME

Series Activities

Series Menu

Basic and Clinical Immunology



Novel Therapies PsA and SpA

Print this Content

Release Date:   May 10, 2017
Expiration Date:   May 10, 2019

Estimated Time of Completion:   45 minutes

Description

Clinical immunology is rapidly evolving, and it is challenging for the practicing clinician to keep abreast of the advances. The Basic and Clinical Immunology Webcast Series provides clinicians with a review of basic and clinical immunology. The webcast series is composed of A-B-C teaching with an emphasis on biologic principles and implications.

This webcast reviews novel therapies in treating PsA and SpA.

Learning Objectives

  1. Describe new concepts in the diagnosis and treatment of psoriatic arthritis and ankylosing spondylitis.
  2. Review new treatment recommendations for PsA and SpA.
  3. Discuss novel and emerging therapies for PsA and SpA.

Target Audience

These activities are directed to rheumatologists, dermatologists, allergists, internal medicine physicians, pulmonologists, nurse practitioners, physician assistants, and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair of Rheumatology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard Calabrese, DO
  Regeneron Consulting
M. Elaine Husni, MD, MPH
  AbbVie Pharmaceuticals; Genentech, Janssen Consulting
  Amgen, Bristol-Myers Squibb Co., Genzyme/Sanofi, Lilly, Regeneron Consulting;
Membership on advisory committee or review panels
  Novartis Pharmaceuticals Consulting;
Teaching and Speaking
  Pfizer, Inc. Membership on advisory committee or review panels

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

AbbVie, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech
Mallinckrodt LLC

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the R.J. Fasenmyer Center for Clinical Immunology.